Nomura Holdings’s Novo Nordisk NVO Stock Holding History

Nomura Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.76M	Buy	+75,000	New	+$3.55M	0.01%	821
2025 Q4	–	Sell	-42,000	Closed	-$2.33M	–	2084
2025 Q3	$2.33M	Sell	42,000 -50,000	-54%	-$2.93M	﹤0.01%	1082
2025 Q2	$6.35M	Sell	92,000 -608,000	-87%	-$41.4M	0.01%	509
2025 Q1	$48.6M	Buy	700,000 +685,000	+4,567%	+$56.6M	0.09%	144
2024 Q4	$1.29M	Buy	15,000 +8,700	+138%	+$941K	﹤0.01%	1328
2024 Q3	$750K	Buy	+6,300	New	+$840K	﹤0.01%	1183

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Nomura Holdings's NVO Position: Q1 2026 in Review

Nomura Holdings increased its Novo Nordisk (NVO) stake by 30% in Q1 2026, buying an estimated $5.02M and bringing the position to 462,909 shares worth $17M. The position accounts for 0.05% of the portfolio, ranked #290.

Nomura Holdings first reported a position in NVO in Q2 2013 and has held it in 18 quarters since. The position peaked at $54.1M in Q3 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Nomura Holdings held 462,909 shares of Novo Nordisk worth $17M as of Q1 2026.
Nomura Holdings bought 106,023 Novo Nordisk shares in Q1 2026, an estimated $5.02M.
Novo Nordisk made up 0.05% of Nomura Holdings's portfolio in Q1 2026, its #290 holding.
Nomura Holdings first reported a position in Novo Nordisk in Q2 2013 and has held it in 18 quarters since.
Nomura Holdings's Novo Nordisk position peaked at $54.1M in Q3 2025.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.